PIONEERS IN PLASMA SURGERY & MEDICINE
MEDIA
LATEST PRESS RELEASES
Rush Cancer Surgeons Perform Country’s First Cold Plasma Adjuvant Therapy
Takoma Park, MD
Canady Cold Atmospheric Plasma Provides New Insight for the Potential Treatment of Breast Cancer
Takoma Park, MD
JCRI-ABTS Seeks FDA Emergency Use Authorization for the Canady Helios Cold Plasma HERO System for the Treatment of COVID-19
Takoma Park, MD
RECENT PUBLICATIONS
Scientific American Top Ten Emerging Technologies of 2019: Canady Cold Plasma
Reduced Blood Loss With Use of Canady Hybrid Plasma Scalpel Compared With Bovie Electrocautery in the Resection of Soft-Tissue Sarcomas
Connor J. Wakefield, BS, Chris Culvern, MS, Matthew W. Colman, MD, Jerome Canady, MD, Steven Gitelis, MD, Alan T. Blank, MD, MS
Read More
RECENT VIDEOS
VIEW USMI’s EDUCATIONAL AND CLINICAL VIDEO LIBRARY
LATEST POSTS

GW Reaches $3.2M Agreement to Support Development of Cold Plasma Technology
The ongoing corporate research partnership between SEAS Professor Michael Keidar and the biotech company US Patent Innovations, LLC employs engineering and translational molecular sciences to develop new medical devices.
gwtoday.gwu.edu

Canady Cold Atmospheric Plasma Provides New Insight for the Potential Treatment of Breast Cancer
The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS) in collaboration with US Medical Innovations, LLC
businesswire.com
Canady Biotechnology proudly manufactures our products in the USA
Keep America Strong
6930 Carroll Avenue, Suite 1000
Takoma Park, Maryland 20912
US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA registered life science and biomedical device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives.